{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T14:20:35Z","timestamp":1726064435402},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T00:00:00Z","timestamp":1530576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00535-018-1490-y","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T05:45:15Z","timestamp":1530596715000},"page":"141-148","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A genetic variant located in the miR-532-5p-binding site of TGFBR1 is associated with the colorectal cancer risk"],"prefix":"10.1007","volume":"54","author":[{"given":"Dongying","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mulong","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuiju","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengdong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,3]]},"reference":[{"key":"1490_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3322\/caac.21395","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177\u201393.","journal-title":"CA Cancer J Clin"},{"key":"1490_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115\u201332.","journal-title":"CA Cancer J Clin"},{"key":"1490_CR3","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nrc1453","volume":"4","author":"A Chapelle de la","year":"2004","unstructured":"de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer. 2004;4:769\u201380.","journal-title":"Nat Rev Cancer"},{"key":"1490_CR4","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1136\/gutjnl-2013-306705","volume":"64","author":"U Peters","year":"2015","unstructured":"Peters U, Bien S, Zubair N. Genetic architecture of colorectal cancer. Gut. 2015;64:1623\u201336.","journal-title":"Gut"},{"key":"1490_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nrg2574","volume":"10","author":"A Tenesa","year":"2009","unstructured":"Tenesa A, Dunlop MG. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat Rev Genet. 2009;10:353\u20138.","journal-title":"Nat Rev Genet"},{"key":"1490_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2853","volume":"10","author":"H Ikushima","year":"2010","unstructured":"Ikushima H, Miyazono K. TGFbeta signalling: a complex web in cancer progression. Nat Rev Cancer. 2010;10:415\u201324.","journal-title":"Nat Rev Cancer"},{"key":"1490_CR7","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM200005043421807","volume":"342","author":"GC Blobe","year":"2000","unstructured":"Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med. 2000;342:1350\u20138.","journal-title":"N Engl J Med"},{"key":"1490_CR8","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1126\/science.1159397","volume":"321","author":"L Valle","year":"2008","unstructured":"Valle L, Serena-Acedo T, Liyanarachchi S, et al. Germline allele-specific expression of TGFBR1 confers an increased risk of colorectal cancer. Science. 2008;321:1361\u20135.","journal-title":"Science"},{"key":"1490_CR9","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/carcin\/bgs395","volume":"34","author":"R Zhong","year":"2013","unstructured":"Zhong R, Liu L, Zou L, et al. Genetic variations in the TGFbeta signaling pathway, smoking and risk of colorectal cancer in a Chinese population. Carcinogenesis. 2013;34:936\u201342.","journal-title":"Carcinogenesis"},{"key":"1490_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nrc2867","volume":"10","author":"BM Ryan","year":"2010","unstructured":"Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer. 2010;10:389\u2013402.","journal-title":"Nat Rev Cancer"},{"key":"1490_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281\u201397.","journal-title":"Cell"},{"key":"1490_CR12","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00204-012-1004-2","volume":"87","author":"L Ma","year":"2013","unstructured":"Ma L, Zhu L, Gu D, et al. A genetic variant in miR-146a modifies colorectal cancer susceptibility in a Chinese population. Arch Toxicol. 2013;87:825\u201333.","journal-title":"Arch Toxicol"},{"key":"1490_CR13","doi-asserted-by":"publisher","first-page":"e05005","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal V, Bell GW, Nam JW, et al. Predicting effective microRNA target sites in mammalian mRNAs. eLife. 2015;4:e05005.","journal-title":"eLife"},{"key":"1490_CR14","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3390\/cancers5020676","volume":"5","author":"K Bardhan","year":"2013","unstructured":"Bardhan K, Liu K. Epigenetics and colorectal cancer pathogenesis. Cancers (Basel). 2013;5:676\u2013713.","journal-title":"Cancers (Basel)"},{"key":"1490_CR15","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1056\/NEJMra0804588","volume":"361","author":"SD Markowitz","year":"2009","unstructured":"Markowitz SD, Bertagnolli MM. Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med. 2009;361:2449\u201360.","journal-title":"N Engl J Med"},{"key":"1490_CR16","doi-asserted-by":"publisher","first-page":"10442","DOI":"10.1038\/srep10442","volume":"5","author":"NA Al-Tassan","year":"2015","unstructured":"Al-Tassan NA, Whiffin N, Hosking FJ, et al. A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer. Sci Rep. 2015;5:10442.","journal-title":"Sci Rep"},{"key":"1490_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-1-4419-6033-7_5","volume":"155","author":"N Bellam","year":"2010","unstructured":"Bellam N, Pasche B. Tgf-beta signaling alterations and colon cancer. Cancer Treat Res. 2010;155:85\u2013103.","journal-title":"Cancer Treat Res"},{"key":"1490_CR18","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1001\/jama.294.13.1634","volume":"294","author":"B Pasche","year":"2005","unstructured":"Pasche B, Knobloch TJ, Bian Y, et al. Somatic acquisition and signaling of TGFBR1*6A in cancer. JAMA. 2005;294:1634\u201346.","journal-title":"JAMA"},{"key":"1490_CR19","doi-asserted-by":"publisher","first-page":"e42899","DOI":"10.1371\/journal.pone.0042899","volume":"7","author":"YQ Wang","year":"2012","unstructured":"Wang YQ, Qi XW, Wang F, et al. Association between TGFBR1 polymorphisms and cancer risk: a meta-analysis of 35 case-control studies. PLoS One. 2012;7:e42899.","journal-title":"PLoS One"},{"key":"1490_CR20","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1007\/s11033-011-1009-6","volume":"39","author":"X Zhang","year":"2012","unstructured":"Zhang X, Wu L, Sheng Y, et al. The association of polymorphisms on TGFBR1 and colorectal cancer risk: a meta-analysis. Mol Biol Rep. 2012;39:2567\u201374.","journal-title":"Mol Biol Rep"},{"key":"1490_CR21","doi-asserted-by":"publisher","first-page":"7080","DOI":"10.1038\/srep07080","volume":"4","author":"P Song","year":"2014","unstructured":"Song P, Zhu H, Zhang D, et al. A genetic variant of miR-148a binding site in the SCRN1 3\u2032-UTR is associated with susceptibility and prognosis of gastric cancer. Sci Rep. 2014;4:7080.","journal-title":"Sci Rep"},{"key":"1490_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/ijc.29978","volume":"139","author":"M Wang","year":"2016","unstructured":"Wang M, Du M, Ma L, et al. A functional variant in TP63 at 3q28 associated with bladder cancer risk by creating an miR-140-5p binding site. Int J Cancer. 2016;139:65\u201374.","journal-title":"Int J Cancer"},{"key":"1490_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12943-015-0301-9","volume":"14","author":"YY Chang","year":"2015","unstructured":"Chang YY, Kuo WH, Hung JH, et al. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing. Mol Cancer. 2015;14:36.","journal-title":"Mol Cancer"},{"key":"1490_CR24","doi-asserted-by":"publisher","first-page":"e0125672","DOI":"10.1371\/journal.pone.0125672","volume":"10","author":"H He","year":"2015","unstructured":"He H, Wang L, Zhou W, et al. MicroRNA expression profiling in clear cell renal cell carcinoma: identification and functional validation of key miRNAs. PLoS One. 2015;10:e0125672.","journal-title":"PLoS One"},{"key":"1490_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/1477-7819-10-174","volume":"10","author":"H Lee","year":"2012","unstructured":"Lee H, Park CS, Deftereos G, et al. MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features. World J Surg Oncol. 2012;10:174.","journal-title":"World J Surg Oncol"},{"key":"1490_CR26","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1158\/1535-7163.MCT-15-0943","volume":"15","author":"F Wang","year":"2016","unstructured":"Wang F, Chang JT, Kao CJ, et al. High Expression of miR-532-5p, a tumor suppressor, leads to better prognosis in ovarian cancer both in vivo and in vitro. Mol Cancer Ther. 2016;15:1123\u201331.","journal-title":"Mol Cancer Ther"},{"key":"1490_CR27","first-page":"2254","volume":"7","author":"X Song","year":"2015","unstructured":"Song X, Wang Z, Jin Y, et al. Loss of miR-532-5p in vitro promotes cell proliferation and metastasis by influencing CXCL2 expression in HCC. Am J Transl Res. 2015;7:2254\u201361.","journal-title":"Am J Transl Res"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-018-1490-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-018-1490-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-018-1490-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T18:16:01Z","timestamp":1567016161000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-018-1490-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1490"],"URL":"https:\/\/doi.org\/10.1007\/s00535-018-1490-y","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,3]]},"assertion":[{"value":"2 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors disclose no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}